ArticleACS pharmacology & translational science2023

Preclinical Characterization of 22-(4'-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis

Iksen Iksen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.